
Contact us
About company
Lydex Pharmaceuticals develops small molecule drug therapy for liver ischemia/reperfusion (IR) to prevent additional damage to the liver during surgical procedures and transplants.
US
Unknown
Unknown
Not verified company

Lydex Pharmaceuticals develops small molecule drug therapy for liver ischemia/reperfusion (IR) to prevent additional damage to the liver during surgical procedures and transplants.